Home / Virtual products: Ge / Generic COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted])...
Generic COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted])...
- ID
- 40872511000001107
- Therapeutic Moiety
- COVID-19 vaccine
- Name
- Generic COVID-19 Vaccine VidPrevtyn Beta (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose solution and emulsion for emulsion for injection multidose vials
- Preferred name basis
- Other
- Date of name applicability
- 10 Jan 2023
- Previous name
- Generic COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5ml dose emulsion for injection multidose vials
- Basis of previous name
- Other
- Prescribing status
- Never Valid To Prescribe As A VMP
- Non-availability indicator
- Actual Products not Available
- Non availability status date
- 22 Mar 2024
- Dose form
- Discrete
- Unit dose form size
- 0.500
- Unit dose form units
- ml
- Unit dose unit of measure
- dose
- Form & Route
- emulsioninjection.intramuscular
- Drug formulations
- Solution and emulsion for emulsion for injection
- Drug route
- Intramuscular
- Control drug
- No Controlled Drug Status